Anti-Microbial Savior BioteQ Co., Ltd. (TPEX:6864)

TPEX:6864 Statistics

Total Valuation

TPEX:6864 has a market cap or net worth of TWD 2.38 billion. The enterprise value is 2.19 billion.

Market Cap	2.38B
Enterprise Value	2.19B

Important Dates

The next estimated earnings date is Monday, March 16, 2026.

Earnings Date	Mar 16, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:6864 has 32.53 million shares outstanding.

Current Share Class	32.53M
Shares Outstanding	32.53M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+14.04%
Owned by Insiders (%)	16.01%
Owned by Institutions (%)	n/a
Float	27.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3,891.41
PB Ratio	10.04
P/TBV Ratio	10.04
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-29.39
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-30.20

Financial Position

The company has a current ratio of 19.01, with a Debt / Equity ratio of 0.01.

Current Ratio	19.01
Quick Ratio	18.24
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.03
Interest Coverage	-2,389.91

Financial Efficiency

Return on equity (ROE) is -41.59% and return on invested capital (ROIC) is -26.40%.

Return on Equity (ROE)	-41.59%
Return on Assets (ROA)	-25.41%
Return on Invested Capital (ROIC)	-26.40%
Return on Capital Employed (ROCE)	-32.20%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.00
Inventory Turnover	0.35

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.60% in the last 52 weeks. The beta is 0.02, so TPEX:6864's price volatility has been lower than the market average.

Beta (5Y)	0.02
52-Week Price Change	+5.60%
50-Day Moving Average	79.14
200-Day Moving Average	85.86
Relative Strength Index (RSI)	33.86
Average Volume (20 Days)	99,946

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6864 had revenue of TWD 612,000 and -74.52 million in losses. Loss per share was -2.46.

Revenue	612,000
Gross Profit	144,000
Operating Income	-76.48M
Pretax Income	-74.52M
Net Income	-74.52M
EBITDA	-65.66M
EBIT	-76.48M
Loss Per Share	-2.46

Balance Sheet

The company has 194.13 million in cash and 2.39 million in debt, with a net cash position of 191.74 million or 5.89 per share.

Cash & Cash Equivalents	194.13M
Total Debt	2.39M
Net Cash	191.74M
Net Cash Per Share	5.89
Equity (Book Value)	237.31M
Book Value Per Share	7.35
Working Capital	192.19M

Cash Flow

In the last 12 months, operating cash flow was -64.15 million and capital expenditures -8.37 million, giving a free cash flow of -72.52 million.

Operating Cash Flow	-64.15M
Capital Expenditures	-8.37M
Free Cash Flow	-72.52M
FCF Per Share	-2.23

Margins

Gross Margin	23.53%
Operating Margin	-12,496.24%
Pretax Margin	-12,175.98%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPEX:6864 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.09%
Shareholder Yield	-21.09%
Earnings Yield	-3.13%
FCF Yield	-3.05%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:6864 has an Altman Z-Score of 52.77 and a Piotroski F-Score of 2.

Altman Z-Score	52.77
Piotroski F-Score	2